Quick Takeaways
- WIRTH PETER has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $8,248,624.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of WIRTH PETER
- Location
- Boston, MA
- Summary
- The estimated value of insider holdings of WIRTH PETER is at least $8,248,624 dollars as of 23 Jun 2025. WIRTH PETER is the Director of Zai Lab Ltd and owns shares of Zai Lab Ltd (ZLAB) stock worth about $8.17M. WIRTH PETER is the Director of Syros Pharmaceuticals, Inc. and owns shares of Syros Pharmaceuticals, Inc. stock worth about $79.2K.
- Signature
- /s/ Bruce Blefeld, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow WIRTH PETER and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean.
What Changed
- Largest disclosed position: Zai Lab Ltd ($8,169,424).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of WIRTH PETER
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| ZLAB | Zai Lab Ltd | Director | $8,169,424 | 18 Jun 2025 | ||
| SYRS | Syros Pharmaceuticals, Inc. | Director | $79,200 | 05 Jun 2024 | ||
| FMTX | Forma Therapeutics Holdings, Inc. | Director | 14 Oct 2022 |
Insider Transactions Reported by WIRTH PETER:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.